Sherwood Russ Lehrman

Title: Sherwood Russ Lehrman: Innovator in Pharmaceutical Formulations and Nucleic Acid Classification

Introduction

Sherwood Russ Lehrman is a notable inventor based in Los Altos, California. He has made significant contributions to the fields of pharmaceutical formulations and nucleic acid classification. With a total of five patents to his name, Lehrman has demonstrated a commitment to advancing medical science and technology.

Latest Patents

Lehrman's latest patents include an innovative immunoglobulin formulation and method of preparation. This stable aqueous pharmaceutical formulation comprises a therapeutically effective amount of an antibody, polysorbate 80, and a buffer that inhibits polysorbate oxidation. The formulation is designed to maintain high antibody concentrations while ensuring fixed volumes, making it suitable for patients of varying weights. Another significant patent is related to nucleic acid classification. This method and system involve exposing capture probes to a target nucleic acid in a test system. By establishing different hybridization conditions, the target nucleic acid can be classified based on the degrees of hybridization observed.

Career Highlights

Throughout his career, Sherwood Russ Lehrman has worked with prominent companies in the pharmaceutical industry. He has been associated with Biogen Idec and Elan Pharmaceuticals, where he contributed to various innovative projects. His work has had a lasting impact on the development of therapeutic solutions.

Collaborations

Lehrman has collaborated with several professionals in his field, including David J. Burke and Shaun E. Buckley. These collaborations have further enriched his research and development efforts.

Conclusion

Sherwood Russ Lehrman is a distinguished inventor whose work in pharmaceutical formulations and nucleic acid classification has paved the way for advancements in medical technology. His contributions continue to influence the industry and improve patient care.